These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1615794

  • 1. Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure.
    Stevenson WG, Middlekauff HR, Stevenson LW, Saxon LA, Woo MA, Moser D.
    Am Heart J; 1992 Jul; 124(1):123-30. PubMed ID: 1615794
    [Abstract] [Full Text] [Related]

  • 2. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
    Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN.
    Circulation; 1993 Sep; 88(3):1083-92. PubMed ID: 8353870
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G.
    N Engl J Med; 2000 Jun 29; 342(26):1937-45. PubMed ID: 10874061
    [Abstract] [Full Text] [Related]

  • 4. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
    Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Crijns HJ, Algra A, Wiesfeld AC, Bakker PF, Robles de Medina EO.
    Circulation; 1995 Apr 15; 91(8):2195-203. PubMed ID: 7697849
    [Abstract] [Full Text] [Related]

  • 5. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.
    Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dec GW.
    Circulation; 1995 Dec 01; 92(11):3273-81. PubMed ID: 7586314
    [Abstract] [Full Text] [Related]

  • 6. Results of electrophysiologic testing and long-term prognosis in patients with coronary artery disease and aborted sudden death.
    Sousa J, Rosenheck S, Calkins H, de Buitleir M, Schmaltz S, Kadish A, Morady F.
    Am Heart J; 1991 Oct 01; 122(4 Pt 1):1001-6. PubMed ID: 1927851
    [Abstract] [Full Text] [Related]

  • 7. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
    Kiès P, Boersma E, Bax JJ, van der Burg AE, Bootsma M, van Erven L, van der Wall EE, Schalij MJ.
    J Cardiovasc Electrophysiol; 2005 Oct 01; 16(10):1049-56. PubMed ID: 16191114
    [Abstract] [Full Text] [Related]

  • 8. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
    Meinertz T, Zehender M, Hofmann T, Hohnloser S, Just H.
    Herz; 1991 Sep 01; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
    [Abstract] [Full Text] [Related]

  • 9. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G.
    N Engl J Med; 1999 Dec 16; 341(25):1882-90. PubMed ID: 10601507
    [Abstract] [Full Text] [Related]

  • 10. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
    Siebels J, Kuck KH.
    Am Heart J; 1994 Apr 16; 127(4 Pt 2):1139-44. PubMed ID: 8160593
    [Abstract] [Full Text] [Related]

  • 11. Influence of left ventricular function on outcome of patients treated with implantable defibrillators.
    Kim SG, Fisher JD, Choue CW, Gross J, Roth J, Ferrick KJ, Brodman R, Furman S.
    Circulation; 1992 Apr 16; 85(4):1304-10. PubMed ID: 1555274
    [Abstract] [Full Text] [Related]

  • 12. Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation.
    Andresen D, Steinbeck G, Brüggemann T, Haberl R, Fink L, Schröder R.
    Am J Cardiol; 1992 Nov 15; 70(15):1250-4. PubMed ID: 1442574
    [Abstract] [Full Text] [Related]

  • 13. The long-term prognosis of patients with out-of-hospital cardiac arrest but no inducible ventricular tachycardia.
    Sager PT, Choudhary R, Leon C, Rahimtoola SH, Bhandari AK.
    Am Heart J; 1990 Dec 15; 120(6 Pt 1):1334-42. PubMed ID: 2248180
    [Abstract] [Full Text] [Related]

  • 14. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
    Silka MJ, Kron J, Dunnigan A, Dick M.
    Circulation; 1993 Mar 15; 87(3):800-7. PubMed ID: 8443901
    [Abstract] [Full Text] [Related]

  • 15. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.
    Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, Moriguchi JD, Laks H, Wiener I.
    Am J Cardiol; 2000 Apr 15; 85(8):981-5. PubMed ID: 10760339
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testing.
    Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Chenarides JG.
    J Am Coll Cardiol; 1992 Mar 15; 19(4):780-8. PubMed ID: 1545074
    [Abstract] [Full Text] [Related]

  • 17. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?
    Sarter BH, Finkle JK, Gerszten RE, Buxton AE.
    J Am Coll Cardiol; 1996 Jul 15; 28(1):122-9. PubMed ID: 8752804
    [Abstract] [Full Text] [Related]

  • 18. Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
    Curtain JP, Docherty KF, Jhund PS, Petrie MC, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Bengtsson O, Langkilde AM, Sjöstrand M, Solomon SD, McMurray JJV.
    Eur Heart J; 2021 Sep 21; 42(36):3727-3738. PubMed ID: 34448003
    [Abstract] [Full Text] [Related]

  • 19. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.
    Am J Cardiol; 2010 Jan 01; 105(1):105-11. PubMed ID: 20102900
    [Abstract] [Full Text] [Related]

  • 20. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB, Sivakumaran S, Essebag V, Dorian P, Tang AS.
    Circ Arrhythm Electrophysiol; 2017 Mar 01; 10(3):. PubMed ID: 28292754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.